CagriSema 2.4mg

CagriSema 2.4mg 化学特性,用途語,生産方法

• 定義

  CagriSema is a fixed-dose combination therapy of 2.4mg semaglutide with 2.4mg cagrilintide, in obesity patients. Cagrilintide is a long-acting amylin analogue potentiating semaglutide’s weight loss effects.

CagriSema 2.4mg 生産企業

Global(1)Suppliers